Insmed
INSM
$25.52
Share price
-3.00%
Change (1 day)
17.28%
Change (1 year)
Operating Margin for Insmed (INSM)
Operating Margin as of September 2023 (TTM): -195.69%
According to Insmed's latest financial reports and stock price the company's current Operating Margin is -195.69%. At the end of 2022 the company had an Operating Margin of -195.69%.
Operating Margin history for Insmed from 2009 to 2008
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -195.69% | -15.49% |
| 2021 | -231.57% | 30.08% |
| 2020 | -178.02% | -4.19% |
| 2019 | -185.80% | -94.36% |
| 2018 | -3,295.13% | |
| 2013 | -498.21% | |
| 2011 | -1,350.78% | 1370.86% |
| 2010 | -91.84% | -108.02% |
| 2009 | 1,145.54% | -1029.96% |
| 2008 | -123.18% | -54.62% |
| 2007 | -271.47% | -95.05% |
| 2006 | -5,486.68% | -73.8% |
| 2005 | -20,941.98% | 4.61% |
| 2004 | -20,018.25% | 183.65% |
| 2003 | -7,057.33% | 278.86% |
| 2002 | -1,862.76% | -85.17% |
| 2001 | -12,557.09% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -108.83% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | 26.84% | -113.72% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | 47.39% | -124.22% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -88.19% | -54.93% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -10.86% | -94.45% | 🇺🇸 USA |
 Array Technologies ARRY | 12.31% | -106.29% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.